Is risperidone appropriate for treating substance cravings?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Risperidone is NOT appropriate for treating substance cravings

Risperidone is not indicated for the treatment of substance cravings and should not be used for this purpose. The available evidence shows that risperidone may actually worsen cravings in some contexts, particularly for cannabis, and there is no established therapeutic benefit for treating substance use disorders.

Evidence Against Use for Cravings

Cannabis Cravings - Risperidone Performs Poorly

The research directly comparing antipsychotics shows that risperidone is associated with significantly higher cannabis craving compared to both clozapine and olanzapine 1. In patients with psychotic disorders and cannabis dependence, those treated with risperidone reported substantially more craving than those on clozapine (p = .001) or olanzapine (p = .025) 1. This suggests risperidone may actually exacerbate rather than reduce cannabis cravings.

Cocaine - Limited and Conflicting Evidence

While one small open-label study (n=16) suggested risperidone might reduce cocaine craving in patients with comorbid psychiatric disorders 2, and another experimental study showed it reduced cocaine-induced euphoria 3, these findings are:

  • From very small samples
  • Not replicated in controlled trials
  • Contradicted by a Cochrane review finding no clear differences between risperidone and other antipsychotics for reducing substance use 4

The comparison study between olanzapine and risperidone showed a trend toward greater cocaine reduction with olanzapine, not risperidone 5.

What Risperidone IS Indicated For

According to FDA labeling, risperidone is approved for 6:

  • Schizophrenia (adults and adolescents)
  • Bipolar mania (adults and pediatrics)
  • Irritability associated with autistic disorder (pediatrics)

None of these indications include substance cravings or substance use disorders.

Evidence-Based Alternatives for Substance Cravings

For actual treatment of substance cravings, the evidence supports 7, 8:

For opioid use disorders:

  • Buprenorphine (FDA-approved for ages 16+)
  • Methadone
  • Naltrexone (including extended-release formulation)

For alcohol use disorders:

  • Acamprosate
  • Naltrexone
  • Topiramate (off-label but evidence-supported) 9

For tobacco:

  • Nicotine replacement therapy
  • Bupropion
  • Varenicline

Critical Caveat

If a patient has co-occurring psychosis or bipolar disorder AND substance use disorder, risperidone may be appropriate for treating the primary psychiatric condition 10. The typical dose for early psychosis is 2 mg/day 10. However, the goal would be treating the psychotic symptoms, not the substance cravings themselves. In fact, clinicians should monitor for potentially increased cannabis cravings when using risperidone in this population 1.

The bottom line: Do not prescribe risperidone specifically to treat substance cravings. Use evidence-based medication-assisted treatments appropriate for the specific substance involved.

Related Questions

What is the recommended rate for titrating risperidone (Risperdal) in an inpatient hospital?
Can risperidone be discontinued abruptly after three days of treatment in a patient who has not developed tolerance?
What is the most appropriate anti-anxiety medication to add for a patient currently treated with risperidone?
How does Risperdal (risperidone) decrease hypersexuality?
If I missed my 4 mg risperidone dose for three days, should I take it today?
In a veteran aviation mechanic/crew chief (MOS 67U/15U) and aviation maintenance officer (151A) who repeatedly climbed and descended CH‑47/UH‑1 helicopters, is the development of a posterior calcaneal (Haglund’s) spur and the need for retrocalcaneal bursectomy at least as likely as not related to his service duties?
How long should anticoagulation be continued after a first mild incidentally discovered pulmonary embolism?
What are the possible adverse reactions to ferrelectit (ferrous iron) and how should they be managed?
Which antiarrhythmic agents are contraindicated in patients with structural heart disease (e.g., prior myocardial infarction, left ventricular systolic dysfunction, cardiomyopathy, significant left ventricular hypertrophy, or valvular disease)?
Is severe patellofemoral compartment disease a form of osteoarthritis?
In a morbidly obese (BMI ≥ 40 kg/m²) smoker with an incidentally discovered venous thromboembolism and no identifiable provoking factor, what is the recommended anticoagulation regimen and duration?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.